Unnamed Pharmaceuticals: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Unnamed Pharmaceuticals: Announcement on amending the “Articles of Association” of the participating company Beijing Kexing Biological Products Co., Ltd.
Unnamed Pharmaceuticals: Half-year summary table of non-operating capital usage and other related capital transactions
Unnamed Pharmaceuticals: 2024 Semi-Annual Financial Report
Unnamed Pharmaceuticals: Announcement on the Appointment of a Secretary of the Board
Unnamed Pharmaceuticals: Announcement on the Resignation of the Company\'s Board Secretary
Shandong Sinobioway Biomedicine: Announcement on the Progress of Completing the Internal Transfer of Equity and Business Registration Changes of Subsidiaries.
Shandong Sinobioway Biomedicine: Notice on changing the registered address and business scope of the subsidiary and amending the subsidiary's “Articles of Association”
Shandong Sinobioway Biomedicine: Announcement on the withdrawal of the M&A fund
Shandong Sinobioway Biomedicine: Announcement on the resignation of the company's senior management
Shandong Sinobioway Biomedicine: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Shandong Sinobioway Biomedicine: Legal Opinion of the 2023 Annual General Meeting of Shareholders of Shandong Weiming Biomedical Co., Ltd.
Shandong Sinobioway Biomedicine: Announcement on receiving dividends from participating companies
Shandong Sinobioway Biomedicine: Internal Control Self-Assessment Report
Shandong Sinobioway Biomedicine: Notice on Using Idle Own Funds to Purchase Wealth Management Products
Shandong Sinobioway Biomedicine: 2023 Internal Control Rules Implementation Self-Inspection Form
Shandong Sinobioway Biomedicine: Shareholder return plan for the next three years (2024-2026)
Shandong Sinobioway Biomedicine: Summary table on the use of non-operating capital and other related capital transactions in 2023
Shandong Sinobioway Biomedicine: Notice on waiver of preferential purchasing rights
Shandong Sinobioway Biomedicine: Announcement on preparation for impairment of assets accrued in 2023
No Data
No Data